Mutual Fund Sep 2020 share holdings and fund action in GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660

Expensive Performer

Download real time

2650.95 -77.45 (-2.84%)

43.91% Gain from 52W Low

21,051 NSE+BSE Volume

NSE 09 Apr, 2025 10:19 AM (IST)

0.3

MF holding change 1Month %

0.2

MF holding change 2Month %

0.2

MF holding change 3Month%

MF	Sep-2020					Aug-2020		Jul-2020
MF	AUM (Rs Cr)	AUM %	Shares Held	Month Change in Shares	Month Change in Shares %	Shares Held	Month Change in Shares %	Shares Held	Month Change in Shares %
ITI ELSS Tax Saver Fund Regular Growth	0.59	1.47%	3,720	-1,000	-21.19%	4,720	0%	4,720	103.45%
ITI Balanced Advantage Fund Regular Growth	-	-%	-	-	-%	-	-%	0	-100%
ITI Multi Cap Fund Regular Growth	1.98	1.42%	12,585	-10,145	-44.63%	22,730	0%	22,730	0%
Tata Retirement Savings Progressive Fund Growth	8.59	1.05%	54,560	0	0%	54,560	0%	54,560	0%
Tata Retirement Savings Moderate Fund Growth	11.23	0.95%	71,280	0	0%	71,280	0%	71,280	0%
Tata Retirement Savings Conservative Fund Growth	0.49	0.33%	3,080	0	0%	3,080	0%	3,080	0%
UTI MNC Fund Regular Plan Growth	34.02	1.56%	216,000	0	0%	216,000	0%	216,000	0%
Tata Flexi Cap Fund Regular Growth	17.33	1.01%	110,000	0	0%	110,000	0%	110,000	0%
Motilal Oswal Nifty Midcap 150 Index Fund Regular Growth	0.46	0.71%	2,935	306	11.64%	2,629	-12.01%	2,988	1.08%
Shriram Aggresive Hybrid Fund Regular Growth	0	-%	0	-396	-100%	396	0%	396	0%
Shriram Flexi Cap Fund Regular Growth	0	-%	0	-581	-100%	581	0%	581	0%
Shriram ELSS Tax Saver Fund Regular Growth	0	-%	0	-182	-100%	182	0%	182	0%
Baroda BNP Paribas Aggressive Equity Hybrid Regular Growth	0	-%	0	-25,000	-100%	25,000	-50%	50,000	0%
Aditya Birla Sun Life MNC Fund Payout Inc Dist cum Cap Wdrl	274.12	7.24%	1,740,296	0	0%	1,740,296	0%	1,740,296	0%
Aditya Birla Sun Life ELSS Tax Saver Pyt of Inc Dis cum Cap Wdrl	574.84	5.17%	3,649,454	0	0%	3,649,454	0.46%	3,632,730	0%
Baroda BNP Paribas India Consumption Regular Growth	5.91	1.08%	37,500	-33,274	-47.01%	70,774	-24.12%	93,274	0%
Baroda BNP Paribas Conservative Hybrid Fund Regular Plan Growth	0	-%	0	-15,000	-100%	15,000	0%	15,000	0%
Baroda BNP Paribas Mid Cap Fund Regular Plan Growth	7.72	1.06%	49,000	0	0%	49,000	-20.97%	62,000	3.51%
Edelweiss Large Cap Fund Growth	0	-%	0	-4,296	-100%	4,296	0%	4,296	0%
Aditya Birla Sun Life Bal Bhavishya Yojna Regular Growth	14.37	4.95%	91,256	0	0%	91,256	2.01%	89,456	0%
Quant Focused fund Growth	-	-%	-	-	-%	-	-%	0	-100%
Nippon India Pharma Fund - Growth	0	-%	0	-75,200	-100%	75,200	401.33%	15,000	0%
SBI Magnum Midcap Fund Regular Growth	17.07	0.47%	108,396	0	0%	108,396	0%	108,396	0%
ICICI Prudential BSE 500 ETF	0.04	0.10%	237	0	0%	237	-12.22%	270	-16.92%
Quant Absolute Fund Growth	-	-%	-	-	-%	-	-%	0	-100%
Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth	7.88	1.56%	50,000	0	0%	50,000	0%	50,000	0%
Groww Value Fund Regular Growth	0.32	2.03%	2,000	0	0%	2,000	0%	2,000	0%
Aditya Birla Sun Life India GenNext Fund Growth	14.81	0.97%	94,044	0	0%	94,044	0%	94,044	0%
BNP Paribas Dynamic Equity Fund Regular Growth	-	-%	-	-	-%	0	-100%	12,000	0%
Quant Flexi Cap Fund Growth	-	-%	-	-	-%	-	-%	0	-100%
Nippon India ETF Nifty Midcap 150	1.24	0.72%	7,852	648	9.00%	7,204	-20.54%	9,066	-16.16%
ICICI Prudential Nifty Midcap 150 ETF	0.23	0.71%	1,429	226	18.79%	1,203	-29.65%	1,710	-3.50%
Bank of India Mid & Small Cap Equity & Debt Fund Regular Growth	-	-%	-	-	-%	0	-100%	29,000	0%
Quant Mid Cap Fund Growth	-	-%	-	-	-%	-	-%	0	-100%
Quant ELSS Tax Saver Growth	-	-%	-	-	-%	-	-%	0	-100%
Aditya Birla Sun Life Tax Pln Pyt of Inc Dis cum Cap Wdrl	26.70	5.15%	169,521	0	0%	169,521	-7.70%	183,671	0%
Baroda BNP Paribas Large Cap Fund Regular Plan Growth	0	-%	0	-60,000	-100%	60,000	-42.86%	105,000	0%
SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl	-	-%	-	-	-%	0	-100%	142,500	-5%
Taurus Flexi Cap Fund - Growth	2.67	1.33%	16,983	-2,909	-14.62%	19,892	-9.22%	21,913	11.16%
Taurus Discovery (Midcap) Fund - Growth Option	0.20	0.38%	1,294	-794	-38.03%	2,088	-6.70%	2,238	0%
Bank of India Large & Mid Cap Equity Fund Regular Growth	-	-%	-	-	-%	0	-100%	11,600	0%
Nippon India Quant Fund - Growth	0	-%	0	-1,920	-100%	1,920	0%	1,920	100%
Taurus Ethical Fund - Growth Option	0.35	0.81%	2,246	-408	-15.37%	2,654	-10.16%	2,954	0%
Quant Large and Mid Cap Fund Growth	-	-%	-	-	-%	-	-%	0	-100%
SBI Bluechip Fund Regular Growth	142.49	0.65%	904,621	0	0%	904,621	0%	904,621	0%
Aditya Birla Sun Life Retirement Fund - The 30s Pln Regular Growth	7.81	5.13%	49,587	0	0%	49,587	1.02%	49,087	0%
Aditya Birla Sun Life Retirement Fund - The 40s Pln Regular Growth	2.83	3.83%	17,986	0	0%	17,986	-21.32%	22,860	0%
ICICI Prudential MNC Fund Regular Growth	6.37	1.19%	40,429	0	0%	40,429	0%	40,429	0%
Groww ELSS Tax Saver Growth	0.95	1.14%	6,000	0	0%	6,000	0%	6,000	0%
Motilal Oswal Nifty 500 Fund Regular Growth	0.06	0.10%	359	20	5.90%	339	1.80%	333	6.05%
Quant Active Fund Growth	-	-%	-	-	-%	-	-%	0	-100%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth	10.64	0.54%	67,535	0	0%	67,535	0%	67,535	0%
Groww Large Cap Fund Regular Plan Growth	1.58	1.23%	10,000	0	0%	10,000	0%	10,000	0%
SBI Magnum Children's Benefit Fund Regular Growth	0	-%	0	-1,125	-100%	1,125	100%	-	-%
Baroda BNP Paribas Large and Mid Cap Fund Regular Growth	7.88	1.42%	50,000	50,000	100%	-	-%	-	-%
Total:			7,642,185	-181,030		7,823,215		8,067,716

43.91% Gain from 52W Low

Baroda BNP Paribas Large and Mid Cap Fund Regular Growth was the highest buyer of 50,000 shares in Sep 2020 constituting 0.03% of the paid up equity of the company.

Nippon India Pharma Fund - Growth was the highest seller of 75,200 shares in Sep 2020 constituting 0.04% of the paid up equity of the company.

Shareholding Stock Screeners

43.91% Gain from 52W Low

Mutual Fund Sep 2020 share holdings and fund action in GlaxoSmithKline Pharmaceuticals Ltd.

5 MFs bought and 16 MFs sold GlaxoSmithKline Pharmaceuticals Ltd. in the month of Sep 2020 for a net change of 181,030 stocks

Baroda BNP Paribas Large and Mid Cap Fund Regular Growth was the highest buyer of 50,000 shares in Sep 2020 constituting 0.03% of the paid up equity of the company.

Nippon India Pharma Fund - Growth was the highest seller of 75,200 shares in Sep 2020 constituting 0.04% of the paid up equity of the company.

Shareholding Stock Screeners